✨ Your Portfolio is fetched and updated from zerodha.
Micro Hospitals
Market Cap
₹134 Cr.
P/E
67.56
About
Vaidya Sane Ayurved Laboratories Limited specializes in treating chronic ailments such as cardiac disease, diabetes, hypertension, and obesity by integrating modern technology with traditional Ayurved… Read more
Vaidya Sane Ayurved Laboratories Limited specializes in treating chronic ailments such as card… Read more
Low
81
52W Range
High
217
  • Vaidya Sane Ayur Lab
  • Murae Organisor
  • Denis Chem Lab

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

7 Yes

Positive for this company

3 Neutral

Neutral for this company

6 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Operating Profit Break-Up

Capex

Asset Break-Up

Segment Wise Break-Up

Peer Comparison
Corporate Actions
Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less
FAQs on Vaidya Sane Ayurved Laboratories Ltd. Business

Vaidya Sane Ayurved Laboratories Limited in India offers specialized treatment for chronic ailments like cardiac disease, diabetes, hypertension, and obesity using a mix of modern technology and traditional Ayurveda practices.

Vaidya Sane Ayur Lab major competitors are Murae Organisor, Denis Chem Lab, Bharat Immunological, Krebs Biochem.&Inds, Makers Laboratories, Achyut Healthcare, Biofil Chem & Pharma.
Market Cap of Vaidya Sane Ayur Lab is ₹134 Crs.
While the median market cap of its peers are ₹104 Crs.

Vaidya Sane Ayur Lab seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation Mar Mar Sep Mar Sep
Conference Call Mar Jun Sep Jun
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material